Department of Obstetrics & Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
J Cell Mol Med. 2021 Feb;25(4):2000-2012. doi: 10.1111/jcmm.16039. Epub 2020 Dec 28.
Endometriosis is a common multi-factorial gynaecological disease. Recent studies have revealed that long non-coding RNAs (lncRNAs) are involved in the pathogenesis of endometriosis. In the present study, the expression profiles of lncRNAs in 6 pairs of endometriosis ectopic endometrium (ecEM) and eutopic endometrium (euEM) tissues were analysed by RNA sequencing. From the profiles, LINC01116 was found to be up-regulated in ecEM tissues compared to euEM tissues and was verified by quantitative real-time PCR (qRT-PCR). Then, functional experiments demonstrated that LINC01116 promoted the proliferation and migration of ectopic primary endometrial stromal cells (ESCs), while miR-9-5p exerted the opposite effects. Dual-luciferase reporter assays verified that LINC01116 directly sponged miR-9-5p and relieved the suppression of its target, Forkhead box protein P1 (FOXP1). Rescue experiments further demonstrated that LINC01116 could promote proliferation and migration of ESCs by targeting FOXP1 via sponging miR-9-5p. Overall, our study illuminates that LINC01116 promotes the progression of endometriosis through the miR-9-5p/FOXP1 axis. This finding provides a novel therapeutic target for patients with endometriosis.
子宫内膜异位症是一种常见的多因素妇科疾病。最近的研究表明,长链非编码 RNA(lncRNA)参与了子宫内膜异位症的发病机制。在本研究中,通过 RNA 测序分析了 6 对子宫内膜异位症异位内膜(ecEM)和在位内膜(euEM)组织中 lncRNA 的表达谱。从这些谱中发现,LINC01116 在 ecEM 组织中比 euEM 组织中上调,并通过定量实时 PCR(qRT-PCR)得到验证。然后,功能实验表明 LINC01116 促进了异位原发性子宫内膜基质细胞(ESCs)的增殖和迁移,而 miR-9-5p 则产生相反的效果。双荧光素酶报告实验验证了 LINC01116 可以通过直接吸附 miR-9-5p 并解除其靶标叉头框蛋白 P1(FOXP1)的抑制作用来发挥作用。挽救实验进一步表明,LINC01116 可以通过靶向 FOXP1 并通过吸附 miR-9-5p 来促进 ESCs 的增殖和迁移。总的来说,我们的研究表明 LINC01116 通过 miR-9-5p/FOXP1 轴促进了子宫内膜异位症的进展。这一发现为子宫内膜异位症患者提供了一个新的治疗靶点。